vitamin d

(Inderscience Publishers) A form of vitamin D could protect us against damage from low levels of radiation according to new research to be published in the International Journal of Low Radiation.

(Ketchum) Pan-European research reveals majority of osteoporosis patients not receiving recommended combination of calcium and vitamin D with treatment.

Individuals with lower blood levels of vitamin D appear to have an increased risk of death overall and from cardiovascular causes, according to a new report.

Many healthy infants and toddlers may have low levels of vitamin D, and about one-third of those appear to have some evidence of reduced bone mineral content on X-rays, according to a new article.

For patients with moderate to severe chronic kidney disease, treatment with activated vitamin D may reduce the risk of death by approximately one-fourth, suggests a new study.

Scientists have found evidence to suggest an important role for vitamin D in brain development and function, and that supplementation for groups chronically low in vitamin D is warranted.

Vitamin D is present in only a few foods (e.g., fatty fish), and is also added to fortified milk, but our supply typically comes mostly from exposure to ultraviolet rays in sunlight.

People with low vitamin D levels may face an increased risk for peripheral artery disease, according to scientists.

PAD is a common disease that occurs when arteries in the legs become narrowed by fatty deposits, causing pain and numbness and impairing the ability to walk.

Researchers have found that, in animal studies, a synthetic form of active vitamin D has a substantive preventive effect on the development of both estrogen receptor (ER)-positive and ER-negative breast cancers.

Unlike many of the other synthetic vitamin D agents that have been tested in humans, this compound, known as Gemini 0097, shows no toxicity, they report.

The research team found that daily injections of Gemini 0097 cut growth of ER-positive cancer by 60 percent in rat studies, and reduced ER-negative breast cancer by half in mice.